These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.


  • J0120

    Injection, tetracycline, up to 250 mg
  • J0129

    Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J0130

    Injection abciximab, 10 mg
  • J0131

    Injection, acetaminophen, 10 mg
  • J0132

    Injection, acetylcysteine, 100 mg
  • J0133

    Injection, acyclovir, 5 mg
  • J0135

    Injection, adalimumab, 20 mg
  • J0150

    Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
  • J0151

    Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
  • J0152

    Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270)


  • Continued
  • J0153

    Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
  • J0171

    Injection, adrenalin, epinephrine, 0.1 mg
  • J0178

    Injection, aflibercept, 1 mg
  • J0180

    Injection, agalsidase beta, 1 mg
  • J0190

    Injection, biperiden lactate, per 5 mg
  • J0200

    Injection, alatrofloxacin mesylate, 100 mg
  • J0202

    Injection, alemtuzumab, 1 mg
  • J0205

    Injection, alglucerase, per 10 units
  • J0207

    Injection, amifostine, 500 mg
  • J0210

    Injection, methyldopate hcl, up to 250 mg
  • J0215

    Injection, alefacept, 0.5 mg
  • J0220

    Injection, alglucosidase alfa, 10 mg, not otherwise specified
  • J0221

    Injection, alglucosidase alfa, (lumizyme), 10 mg
  • J0256

    Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg
  • J0257

    Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg
  • J0270

    Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J0275

    Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J0278

    Injection, amikacin sulfate, 100 mg
  • J0280

    Injection, aminophyllin, up to 250 mg
  • J0282

    Injection, amiodarone hydrochloride, 30 mg
  • J0285

    Injection, amphotericin b, 50 mg
  • J0287

    Injection, amphotericin b lipid complex, 10 mg
  • J0288

    Injection, amphotericin b cholesteryl sulfate complex, 10 mg
  • J0289

    Injection, amphotericin b liposome, 10 mg
  • J0290

    Injection, ampicillin sodium, 500 mg
  • J0295

    Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm
  • J0300

    Injection, amobarbital, up to 125 mg
  • J0330

    Injection, succinylcholine chloride, up to 20 mg
  • J0348

    Injection, anidulafungin, 1 mg
  • J0350

    Injection, anistreplase, per 30 units
  • J0360

    Injection, hydralazine hcl, up to 20 mg
  • J0364

    Injection, apomorphine hydrochloride, 1 mg
  • J0365

    Injection, aprotonin, 10,000 kiu
  • J0380

    Injection, metaraminol bitartrate, per 10 mg
  • J0390

    Injection, chloroquine hydrochloride, up to 250 mg
  • J0395

    Injection, arbutamine hcl, 1 mg
  • J0400

    Injection, aripiprazole, intramuscular, 0.25 mg
  • J0401

    Injection, aripiprazole, extended release, 1 mg
  • J0456

    Injection, azithromycin, 500 mg
  • J0461

    Injection, atropine sulfate, 0.01 mg